US Edition
News from netnews1.com
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top netnews1.com News
Amazon · United StatesAmazon will cut about 14,000 corporate jobs as the online retail giant ramps up spending on artificial intelligence while cutting costs elsewhere. In June CEO Andy Jassy, who has aggressively sought to cut costs since becoming CEO in 2021, said that he anticipated generative AI would reduce Amazon’s corporate workforce in the next few years.See the Story
Amazon cuts 14,000 corporate jobs as spending on artificial intelligence accelerates
55% Center coverage: 417 sources
Cricket · MumbaiIn the last match that Sarfaraz Khan played for India A, he scored 92 against England Lions in Canterbury. While the series was a build-up to the five-Test series against England, the 27-year-old wasn’t part of India’s Test side.See the Story
Sarfaraz Khan doesn’t need India A matches, he can straightaway play internationals if he scores: Shardul
Coverage: 6 sources
United States · United StatesTrump administration officials pledged Monday that major reforms for biosimilar drug approvals will expand access and lower prices for some of the most expensive drugs on the market. Food and Drug Administration Commissioner Marty Makary and Centers for Medicare and Medicaid Services Administrator Mehmet Oz outlined further details about the Trump administration’s plan to slash regulations on biosimilar drug development in an op-ed on Monday. Th…See the Story
Dr. Oz and FDA Chief Say Biosimilar Drug Reform Will Lower Prices
100% Right coverage: 2 sources
